Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis
Alessandro Rizzo, Veronica Mollica, Francesco Massari
Topics & Concepts
MedicineInternal medicineOncologyMetastatic Urothelial CarcinomaHazard ratioMeta-analysisCochrane LibraryChemotherapyBiomarkerConfidence intervalBladder cancerCancerUrothelial carcinomaChemistryBiochemistryBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis